Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2158419
Max Phase: Preclinical
Molecular Formula: C52H44N4O14S2
Molecular Weight: 1013.07
Molecule Type: Small molecule
Associated Items:
ID: ALA2158419
Max Phase: Preclinical
Molecular Formula: C52H44N4O14S2
Molecular Weight: 1013.07
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc([C@H]2[C@](NC(=O)c3ccc(NC(=O)C4CC4)cc3)(C(=O)O)[C@@H](c3ccc(OC(=O)c4cccs4)c(OC)c3)[C@]2(NC(=O)c2ccc(NC(=O)C3CC3)cc2)C(=O)O)ccc1OC(=O)c1cccs1
Standard InChI: InChI=1S/C52H44N4O14S2/c1-67-37-25-31(15-21-35(37)69-47(61)39-5-3-23-71-39)41-51(49(63)64,55-45(59)29-11-17-33(18-12-29)53-43(57)27-7-8-27)42(32-16-22-36(38(26-32)68-2)70-48(62)40-6-4-24-72-40)52(41,50(65)66)56-46(60)30-13-19-34(20-14-30)54-44(58)28-9-10-28/h3-6,11-28,41-42H,7-10H2,1-2H3,(H,53,57)(H,54,58)(H,55,59)(H,56,60)(H,63,64)(H,65,66)/t41-,42+,51+,52-
Standard InChI Key: AIEATBDCHAZWKZ-OKSULDPSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1013.07 | Molecular Weight (Monoisotopic): 1012.2295 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Liu Q, Li N, Yuan Y, Lu H, Wu X, Zhou C, He M, Su H, Zhang M, Wang J, Wang B, Wang Y, Ma D, Ye Y, Weiss HC, Gesing ER, Liao J, Wang MW.. (2012) Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor., 55 (1): [PMID:22103243] [10.1021/jm201150j] |
Source(1):